Furthermore, Fernandez-Zapico et al. showed that, unlike wild-type Vav1, a mutant of Vav1 that lacks its GEF activity cannot rescue the decline in proliferation of cancer cells of pancreatic cells depleted of Vav114. This evidence concerns the gene VAV1 and cancer.